Lymphoma
-
A Treatment That Came Just in TimeCancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
by Laurie Adami
-
Searching the Blood for Signs of Altered ImmunityThe immune systems of people with blood cancer respond differently to infection with the coronavirus than the immune systems of people without cancer or with solid tumors.
by Kate Yandell
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
-
Finding More Targets for CAR-T CellsCAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
-
The Right DoseResearchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.
by Kate Yandell
-
What Not to Say to a Cancer PatientWhen visiting a friend or family member who is sick, it's good to leave platitudes at the door.
by Michael Gavaghen
-
Survivor Profile
A Lesson in ServiceRabbi Ben David was comfortable in his role of helping those in need, but he had to rely on others after his lymphoma diagnosis. The marathon runner has returned to an active life one step at a time.
by Lindsey Konkel
-
From the Editor-in-Chief
CAR-T Cells: ‘Bionic’ Immune Cells for Treating CancerT cells are being rebuilt to kill cancer cells.
by William G. Nelson, MD, PhD
-
Treatment Is WaitingFor patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.
by Sue Rochman
-
Forward Look
Melanoma Risk Increased in Some Lymphoma SurvivorsStudy pinpoints group that may benefit from close surveillance.
by Sharon Reynolds
